Bruker Corporation BRKRP

Full chart Compare
Set alert

Price alert · BRKRP

All alert types
416.81 USD +5.28 (+1.28%)

Nov 3, 2026, 3:54 PM EST

415.07 Day range 434.69
264.30 52-week range 484.90
YTD
+13.88%
1 year
+34.84%
Market cap
8.47B
Revenue (ttm)
3.50B
Profit margin
-2.04%
Dividend
15.94
Ex-dividend date
Aug 13, 2026
YTD return
+13.88%
1-year return
+34.84%
Volume
4.72K
Avg volume
5.82K
Open
421.80
Previous close
411.53
Day's range
415.07 – 434.69
52-week range
264.30 – 484.90
Beta
1.27
Earnings date
Nov 4, 2026

 

No chart data for this range yet.

Key statistics

Enterprise value
66.08B
PEG ratio
0.00
Price / sales
0.00
Price / book
26.33
Dividend yield
3.77%
Payout ratio
0.00%
Revenue growth
5.20%
Free cash flow
179.94M
Total cash
184.90M
Total debt
1.86B
Return on equity
-3.00%
Short % of float
0.00%
50-day average
434.48
200-day average
380.05

Next earnings

Nov 4, 2026

Expected Nov 4, 2026. Consensus EPS estimate 0.00.

Earnings history

Earnings

BRKRP recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2026Sep 30, 20260.4188———
Aug 4, 2026Jun 30, 20260.38480.49+0.11+27.34%
May 6, 2026Mar 31, 20260.22940.31+0.08+35.14%
Feb 12, 2026Dec 31, 20250.650.59-0.06-9.23%
Nov 3, 2025Sep 30, 20250.35370.45+0.10+27.23%
Aug 4, 2025Jun 30, 20250.41150.32-0.09-22.24%

About Bruker Corporation

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
bruker.com

News

Your note

Sign in to keep a note on BRKRP — it syncs with the Stock Master app.

Institution ownership

BRKRP institution ownership
Holder% heldSharesValueReported
Aequim Alternative Investments LP21.01%580,000238.69MJun 29, 2026
FMR, LLC16.18%446,550183.77MJun 29, 2026
Shaw D.E. & Co., Inc.7.43%205,00084.36MJun 29, 2026
Franklin Resources, Inc.7.25%200,00082.31MJun 29, 2026
TPG GP A, LLC6.36%175,50072.22MJun 29, 2026
Blackrock Inc.6.22%171,69570.66MJun 29, 2026

Fund ownership

BRKRP fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Preferred and Income Securities ETF6.06%167,32068.86MSep 29, 2026
Franklin Investors Securities TRT-FRANKLIN CONVERTIBLE SECURITIES Fd.5.67%156,40064.36MJul 30, 2026
Fidelity Securities Fund-Fidelity Growth & Income Portfolio5.57%153,62863.22MAug 30, 2026
CALAMOS INVESTMENT TRUST/IL-Calamos Market Neutral Income Fund3.62%100,00041.15MJul 30, 2026
Fidelity Hastings Street Trust-Fidelity Series Large Cap Stock Fund3.16%87,20035.89MAug 30, 2026
VanEck ETF Trust-VanEck Preferred Securities ex Financials ETF2.54%70,05528.83MSep 29, 2026